Actively Recruiting
Construction and Evaluation of an Artificial Intelligence Assistant Decision-making System Focused on the Treat to Target Framework and Full Process Management for Atopic Dermatitis
Led by West China Hospital · Updated on 2024-10-15
232
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Atopic dermatitis (AD) is a long-lasting skin condition marked by repeated rashes and itching, which seriously impacts patients' quality of life and creates a significant economic burden. Researchers are evaluating an Artificial Intelligence assistant decision-making system (AIADMS) app that integrates the Treat to Target (T2T) strategy to improve disease control and clinical outcomes for patients with moderate to severe AD. This project aims to develop, train, and test the AIADMS app through clinical trials to verify its effectiveness and safety in managing AD. The AIADMS app is designed for both patients and clinicians with features such as reminders, photo uploads, self-evaluation, and data management. The app uses a deep learning model trained on over 10,000 clinical images to assess AD severity and clinical signs. Participants in the treatment group will use the app for disease management and be followed up at scheduled times up to 12 months after treatment, while the control group will receive routine face-to-face care. The app supports Android and iOS and provides automated assessments using tools like EASI, POEM, SCORAD, PP-NRS, and DLQI to help patients and clinicians monitor progress. Participants will have follow-up visits at 2 weeks, 4 weeks, 8 weeks, 12 weeks, 6 months, and 12 months after treatment. During these visits, evaluations using five treatment objectives will be performed. Data collected will include clinical scores, economic consumption, and satisfaction evaluations. The primary outcome is the overall efficiency rate of treatment objectives at 12 weeks. The study also involves tracking safety and patient adherence, with the entire study period lasting up to 12 months.
CONDITIONS
Brief Title
AI App for Management of Atopic Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with atopic dermatitis
- Aged 1 to 75 years
- Able to communicate in Chinese
- Have basic reading and writing skills
- Participant or guardian owns and can use a smartphone or tablet
You will not qualify if you...
- Mental illness or personality disorder
- Language barrier, hearing impairment, or communication difficulties
- Serious coexisting diseases such as cardiopulmonary insufficiency, liver dysfunction, renal dysfunction, blood system diseases, tumors, or other serious conditions
- Other conditions unsuitable for clinical trial participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 12 months
Participants in the app group will use the Artificial Intelligence assistant decision-making system (AIADMS) app to assist in managing atopic dermatitis. Participants in the control group will receive routine face-to-face diagnosis, treatment, and follow-up according to current standards.
Follow-up visits at 2 weeks, 4 weeks, 8 weeks, 12 weeks, 6 months, and 12 months after treatment
Trial Site Locations
Total: 1 location
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610041
Actively Recruiting
Research Team
J
Jingyi Li, M.D.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here